161 related articles for article (PubMed ID: 35739158)
21. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
22. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.
Pu M; Wang J; Huang Q; Zhao G; Xia C; Shang R; Zhang Z; Bian Z; Yang X; Tao K
Tumour Biol; 2017 Jul; 39(7):1010428317709127. PubMed ID: 28714366
[TBL] [Abstract][Full Text] [Related]
23. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
24. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
25. Dynamic evolution of mitochondrial ribosomal proteins in Holozoa.
Scheel BM; Hausdorf B
Mol Phylogenet Evol; 2014 Jul; 76():67-74. PubMed ID: 24631858
[TBL] [Abstract][Full Text] [Related]
26. T-cell receptors provide potential prognostic signatures for breast cancer.
Liu J; Zhang J
Cell Biol Int; 2021 Jun; 45(6):1220-1230. PubMed ID: 33527533
[TBL] [Abstract][Full Text] [Related]
27. Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.
Chen Y; Chen W; Dai X; Zhang C; Zhang Q; Lu J
Int Immunopharmacol; 2020 Oct; 87():106798. PubMed ID: 32693357
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
29. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Tao C; Luo R; Song J; Zhang W; Ran L
J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
[TBL] [Abstract][Full Text] [Related]
30. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
31. High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer.
Jin Q; Liu G; Wang B; Li S; Ni K; Wang C; Ren J; Zhang S; Dai Y
J Clin Pathol; 2020 Dec; 73(12):803-812. PubMed ID: 32404475
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
Zheng A; Zhang L; Song X; Wang Y; Wei M; Jin F
BMC Cancer; 2019 May; 19(1):451. PubMed ID: 31088422
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor's Efficacy for Breast Cancer.
Lv W; Yu H; Han M; Tan Y; Wu M; Zhang J; Wu Y; Zhang Q
Front Immunol; 2022; 13():830158. PubMed ID: 35444644
[TBL] [Abstract][Full Text] [Related]
36. Identification of Candidate Genes Associated with Breast Cancer Prognosis.
Xu YH; Deng JL; Wang LP; Zhang HB; Tang L; Huang Y; Tang J; Wang SM; Wang G
DNA Cell Biol; 2020 Jul; 39(7):1205-1227. PubMed ID: 32456464
[TBL] [Abstract][Full Text] [Related]
37. Nuclear-encoded mitochondrial ribosomal proteins are required to initiate gastrulation.
Cheong A; Archambault D; Degani R; Iverson E; Tremblay KD; Mager J
Development; 2020 May; 147(10):. PubMed ID: 32376682
[TBL] [Abstract][Full Text] [Related]
38. MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.
Tao Z; Suo H; Zhang L; Jin Z; Wang Z; Wang D; Wu M; Peng N; Zhao Y; Chen B
Onco Targets Ther; 2020; 13():12255-12268. PubMed ID: 33273831
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Characterization of the Function of Metabolic Genes and Establishment of a Prediction Model in Breast Cancer.
Yu R; Peng M; Zhao S; Wang Z; Ma Y; Zhang X; Lv X; Wang S; Ju S; Zhao R; Zhou Q; Lian W
Dis Markers; 2022; 2022():3846010. PubMed ID: 35493305
[TBL] [Abstract][Full Text] [Related]
40. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
